Deans' stroke musings: A systematic review of the effect of yogurt consumption on chronic diseases risk markers in adults

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, November 15, 2016

A systematic review of the effect of yogurt consumption on chronic diseases risk markers in adults

I bet this is still not enough to be added to your diet protocol because your doctor and hospital do not translate research into action.
https://www.mdlinx.com/internal-medicine/medical-news-article/2016/11/03/yogurtdairy-productschronic-diseases-risk-markerssystematic-review/6931133/?news_id=466&newsdt=111516&utm_source=DailyNL&utm_medium=newsletter&

European Journal of Nutrition, 11/03/2016

Dumas AA, et al. – Based on the results observed in this study, it can be concluded that the consumption of Lactobacillus bulgaricus and Streptococcus thermophilus (LBST) yogurt indicates either favourable or neutral effects on metabolic risk markers when compared with a control treatment in controlled research settings. Randomised controlled trials (RCTs) exploring the impact of LBST yogurt consumption on metabolic risk markers of chronic diseases are scarce and presented considerable variation in methodologies making comparison between studies difficult.

Methods

In this study, the researchers performed a systematic search in July 2016 in the scientific databases PubMed, EMBASE and The Cochrane Library.
Included studies were RCTs that assessed the effect of consuming yogurt containing LBST as a treatment, and that assessed at least one metabolic risk marker for chronic diseases compared with a control diet or a diet supplemented in another food/ingredient in healthy or chronically ill adults.
7 RCTs including 278 participants were incorporated in the review.
Studies were conducted in the USA, France, Spain, Iran and Canada.
5 studies were undertaken in healthy adults, and 2 were conducted among lactose malabsorbers.
All studies examined changes in blood lipids and glucose homoeostasis, with different doses of yogurt, durations of the supplementation and risks markers evaluated.

Results

Researchers found that consumption of LBST yogurt significantly decreased total cholesterol concentrations, ratio of total cholesterol to HDL-C and plasma glucose compared to a control yogurt-free diet or diet supplemented in another food/ingredient in two out of the seven studies.
The greater part of included RCTs presented high to unclear methodological risks of bias, which brings up issues about the validity of their findings.

Go to PubMed Go to Abstract Print Article Summary Cat 2 CME Report